22157.jpg
Gene Therapy in Rare Diseases Therapeutics Pipeline Report 2024: Analytical Perspective, Current Treatment Patterns, Collaborations, Licensing, Acquisitions
01 août 2024 04h02 HE | Research and Markets
Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "Gene therapy in Rare Diseases - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.Gene therapy in Rare...
Bionano_RGB.png
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
31 juil. 2024 16h01 HE | Bionano Genomics
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the...
Global Gene Therapy Market
Global Gene Therapy Strategic Research Report 2024-2030: Availability of Novel Therapies Drive Market Growth
31 juil. 2024 04h29 HE | Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Gene Therapy is...
Skyquest Logo
Genomics Market Projected to Surpass USD 411.35 Billion by 2031, Witnessing 19.4% CAGR Growth
17 juil. 2024 08h30 HE | SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, July 17, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global Genomics Market will attain a value of USD 411.35 billion by 2031, with a CAGR of 19.4% during the forecast period...
Logo.jpg
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
11 juil. 2024 08h00 HE | ProPhase Labs, Inc.
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value...
PGLogo.jpg
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and Ireland
09 juil. 2024 07h00 HE | Paragon Genomics
Paragon Genomics announced an agreement with Biosecure ID to distribute its CleanPlex® NGS target enrichment products & technology in the UK & Ireland
22157.jpg
Viral Vector Manufacturing Industry Research 2024
03 juil. 2024 10h26 HE | Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Gene Therapy R&D Market Report 2024-2034 - Gene Therapy Resurgence Fuelled by Groundbreaking Advancements, Soaring Investments and a Promising Pipeline Reshaping Medicine's Future
01 juil. 2024 10h10 HE | Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy R&D Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for Gene Therapy R&D Market is...
22157.jpg
Genome Editing Technologies Market Report 2024-2034 - Emerging Economies Projected to Boost Industry Growth
27 juin 2024 07h20 HE | Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Genome Editing Technologies Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Genome Editing...
22157.jpg
Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Research 2023-2031: Stringent Regulatory Requirements, Growing Adoption of Personalized Medicine, Competition to Intensify
27 juin 2024 06h23 HE | Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key...